How does SLNO's EPS trend compare year-over-year?
3/31/2025 04:18pm
Soleno Therapeutics (SLNO) has shown a significant improvement in its EPS trend year-over-year. The company's diluted EPS was -$2.36 for 2023, and it improved to -$4.38 for 2024. This indicates a substantial decrease in the company's losses over the past year, suggesting improved financial performance and stability.
|code|Ticker|Name|Date|Diluted EPS (FY) YoY|Diluted EPS (FY)|market_code|
|---|---|---|---|---|---|---|
|SLNO|SLNO.O|Soleno Therapeutics|2023|17.770034843205583|-2.36|186|
|SLNO|SLNO.O|Soleno Therapeutics|2024|-85.59322033898306|-4.38|186|